Selective stimulation of colonic L cells improves metabolic outcomes in mice
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Abstract Aims/hypothesis Insulin-like peptide-5 (INSL5) is found only in distal colonic L cells, which co-express glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). GLP-1 is a well-known insulin secretagogue, and GLP-1 and PYY are anorexigenic, whereas INSL5 is considered orexigenic. We aimed to clarify the metabolic impact of selective stimulation of distal colonic L cells in mice. Methods Insl5 promoter-driven expression of Gq-coupled Designer Receptor Exclusively Activated by Designer Drugs (DREADD) was employed to activate distal colonic L cells (LdistalDq). IPGTT and food intake were assessed with and without DREADD activation. Results LdistalDq cell stimulation with clozapine N-oxide (CNO; 0.3 mg/kg i.p.) increased plasma GLP-1 and PYY (2.67- and 3.31-fold, respectively); INSL5 was not measurable in plasma but was co-secreted with GLP-1 and PYY in vitro. IPGTT (2 g/kg body weight) revealed significantly improved glucose tolerance following CNO injection. CNO-treated mice also exhibited reduced food intake and body weight after 24 h, and increased defecation, the latter being sensitive to 5-hydroxytryptamine (5-HT) receptor 3 inhibition. Pre-treatment with a GLP1 receptor-blocking antibody neutralised the CNO-dependent improvement in glucose tolerance but did not affect the reduction in food intake, and an independent group of animals pair-fed to the CNO-treatment group demonstrated attenuated weight loss. Pre-treatment with JNJ-31020028, a neuropeptide Y receptor type 2 antagonist, abolished the CNO-dependent effect on food intake. Assessment of whole body physiology in metabolic cages revealed LdistalDq cell stimulation increased energy expenditure and increased activity. Acute CNO-induced food intake and glucose homeostasis outcomes were maintained after 2 weeks on a high-fat diet. Conclusions/interpretation This proof-of-concept study demonstrates that selective distal colonic L cell stimulation has beneficial metabolic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The density of L-cells increases toward the distal end of the gastrointestinal tract, peaking in the ileum and colon—a paradoxical observation given that nutrient-sensing cell density would be expected to be highest in the proximal intestine where nutrient absorption primarily takes place (25, 33).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 1×
“Only under exceptional conditions, or long after a meal, do ingested nutrients reach as far as the colon, and it therefore seems unlikely that colonic GLP-1 and PYY contribute to the incretin effect or early postprandial control of appetite [5].”
BackgroundTolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Self-citationCalculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365 · cited 1×
“V̇O2 and V̇CO2 were used to calculate the respiratory exchange ratio (RER) and energy expenditure (EE) as previously described [20].”
MethodGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · cited 1×
“Glucagon-like peptide (GLP)-1, generated from the gene encoding proglucagon (Gcg) in intestinal L cells, has both insulinotropic and anorexigenic activities, underlying the clinical use of GLP-1 mimetics for the treatment of type 2 diabetes and obesity [2].”
BackgroundSelf-citationRoth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742 · cited 1×
“Cells were stimulated with 10 μmol/l CNO, a pharmacologically inert metabolite of the atypical antipsychotic drug clozapine and ligand for DREADD-Dq [24], which resulted in a significant increase in GLP-1(7–37), INSL5 (A chain) and PYY(1–36) release (Fig.”
MethodChambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E. K., MacDougall, K., Preston, T., Tedford, C., Finlayson, G. S., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307913 · Cited by 1,424 · cited 1×
“Supporting this idea, ingestion of propionate ester, which stimulates release of GLP-1 and PYY from colonic L cells via the SCFA receptor known as free fatty acid receptor 2 (FFAR2), reduced energy intake and weight gain in humans [50], and rectal administration of bile acids in human volunteers also decreased blood g…”
BackgroundEllingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922 · cited 1×
“Plasma GLP-1 levels increase following oral glucose or meal ingestion, but not after intravenous glucose administration, suggesting the circulating peptide is largely gut-derived [32], whereas islet GLP-1 production has largely been reported in models of inflammation and diabetes [17, 33].”
BackgroundSelf-citationEnterochromaffin cells are gut chemosensors that couple to sensory neural pathways
Bellono, N. W., Bayrer, J. R., Leitch, D. B., Castro, J., Zhang, C., O’Donnell, T. A., Brierley, S. M., Ingraham, H. A., & Julius, D. (2017) · Cell · doi:10.1016/j.cell.2017.05.034 · Cited by 910 · cited 1×
“Both Y1R and RXFP4 are predominantly Gi-coupled, but pertussis toxinsensitive stimulation of 5-HT release has been shown downstream ofα2-adrenergic stimulation [48].”
BackgroundGlucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733
Self-citationGorboulev, V., Schürmann, A., Vallon, V., Kipp, H., Jaschke, A., Klessen, D., Friedrich, A., Scherneck, S., Rieg, T., Cunard, R., et al. (2012) · Diabetes · doi:10.2337/db11-1029 · Cited by 687
Self-citationEnteroendocrine Cells: Chemosensors in the Intestinal Epithelium
Gribble, F. M., & Reimann, F. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105439 · Cited by 683 · cited 1×
“Enteroendocrine cells (EECs) are specialised gastrointestinal epithelial cells that regulate physiological processes ranging from intestinal motility and secretion to glucose homeostasis and appetite [1].”
BackgroundSelf-citationChristiansen, C. B., Gabe, M. B. N., Svendsen, B., Dragsted, L. O., Rosenkilde, M. M., & Holst, J. J. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2017 · Cited by 401 · cited 2×
“L cells in the colon and rectum also express G-protein-coupled receptors for shortchain fatty acids (SCFAs) [10] generated by the intestinal microbiome and for bile acids [11], which are incompletely absorbed in the distal ileum and modified by luminal bacteria, although the physiological importance of SCFAs for the r…”
BackgroundBrighton, C. A., Rievaj, J., Kuhre, R. E., Glass, L. L., Schoonjans, K., Holst, J. J., Gribble, F. M., & Reimann, F. (2015) · Endocrinology · doi:10.1210/en.2015-1321 · Cited by 355 · cited 1×
“Colonic L cells are enriched for a variety of G-protein-coupled receptors, but although it would be tempting to speculate that these might be targetable with non-absorbable gut-restricted small molecules, several of the receptors seem to be located basolaterally on L cells [12, 52, 53], requiring local drug absorption.”
BackgroundSelf-citationInsulin Secretion Depends on Intra-islet Glucagon Signaling
Svendsen, B., Larsen, O., Gabe, M. B. N., Christiansen, C. B., Rosenkilde, M. M., Drucker, D. J., & Holst, J. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.018 · Cited by 355 · cited 1×
“Original reports had identified the intestine as the site of bioactive GLP-1 production, whereas pancreatic extracts and perfusates contained very little [29, 30].”
BackgroundAdriaenssens, A. E., Biggs, E. K., Darwish, T., Tadross, J., Sukthankar, T., Girish, M., Polex-Wolf, J., Lam, B. Y., Zvetkova, I., Pan, W., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.013 · Cited by 324 · cited 3×
“] for 6 h, 30% overnight) as previously described [4, 21].”
MethodSelf-citationEnterochromaffin 5-HT cells – A major target for GLP-1 and gut microbial metabolites
Lund, M. L., Egerod, K. L., Engelstoft, M. S., Dmytriyeva, O., Theodorsson, E., Patel, B. A., & Schwartz, T. W. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.004 · Cited by 254 · cited 1×
“Enterochromaffin cells have been shown previously to expressGlp1r [47], but antagonism of GLP1R did not prevent the increased faecal output in our model.”
β Cell tone is defined by proglucagon peptides through cAMP signaling
Capozzi, M. E., Svendsen, B., Encisco, S. E., Lewandowski, S. L., Martin, M. D., Lin, H., Jaffe, J. L., Coch, R. W., Haldeman, J. M., MacDonald, P. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126742 · Cited by 250
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice
Chambers, A. P., Sorrell, J. E., Haller, A., Roelofs, K., Hutch, C. R., Kim, K.-S., Gutierrez-Aguilar, R., Li, B., Drucker, D. J., D’Alessio, D. A., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.008 · Cited by 241 · cited 3×
“The concept of GLP-1 as a gut-derived incretin hormone is not new but is currently controversial, as recent publications have identified the pancreas as a potential alternative source of GLP-1 [15, 16, 28].”
BackgroundProglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
Rouillé, Y., Westermark, G., Martin, S. K., & Steiner, D. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3242 · Cited by 221
Parker, H. E., Adriaenssens, A., Rogers, G., Richards, P., Koepsell, H., Reimann, F., & Gribble, F. M. (2012) · Diabetologia · doi:10.1007/s00125-012-2585-2 · Cited by 211
Self-citationPancreatic and intestinal processing of proglucagon in man
Ørskov, C., Holst, J. J., Poulsen, S. S., & Kirkegaard, P. (1987) · Diabetologia · doi:10.1007/bf00274797 · Cited by 210 · cited 1×
“Original reports had identified the intestine as the site of bioactive GLP-1 production, whereas pancreatic extracts and perfusates contained very little [29, 30].”
BackgroundAction and therapeutic potential of oxyntomodulin
Pocai, A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.001 · Cited by 191
Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery
Larraufie, P., Roberts, G. P., McGavigan, A. K., Kay, R. G., Li, J., Leiter, A., Melvin, A., Biggs, E. K., Ravn, P., Davy, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.047 · Cited by 170 · cited 1×
“, 24 h prior to the IPGTT in a non-crossover design, as described previously [19].”
MethodSelf-citationGlucagon lowers glycemia when β cells are active
Capozzi, M. E., Wait, J. B., Koech, J., Gordon, A. N., Coch, R. W., Svendsen, B., Finan, B., D’Alessio, D. A., & Campbell, J. E. (2019) · JCI Insight · doi:10.1172/jci.insight.129954 · Cited by 165
Intraislet glucagon signaling is critical for maintaining glucose homeostasis
Zhu, L., Dattaroy, D., Pham, J., Wang, L., Barella, L. F., Cui, Y., Wilkins, K. J., Roth, B. L., Hochgeschwender, U., Matschinsky, F. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127994 · Cited by 158
Heredia, D. J., Gershon, M. D., Koh, S. D., Corrigan, R. D., Okamoto, T., & Smith, T. K. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256230 · Cited by 144 · cited 1×
“Studies in mice lacking Tph1, the enzyme responsible for mucosal 5-HT production, also concluded that enterochromaffin cells are important for propagation of colonic migrating motor complexes and pellet propulsion [45].”
BackgroundAdrian, T. E., Gariballa, S., Parekh, K. A., Thomas, S. A., Saâdi, H., Alkaabi, J., Nagelkerke, N. J. D., Gedulin, B. R., & Young, A. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2593-2 · Cited by 144 · cited 1×
“Supporting this idea, ingestion of propionate ester, which stimulates release of GLP-1 and PYY from colonic L cells via the SCFA receptor known as free fatty acid receptor 2 (FFAR2), reduced energy intake and weight gain in humans [50], and rectal administration of bile acids in human volunteers also decreased blood g…”
BackgroundInsulin-like peptide 5 is an orexigenic gastrointestinal hormone
Grosse, J., Heffron, H., Burling, K., Akhter Hossain, M., Habib, A. M., Rogers, G. J., Richards, P., Larder, R., Rimmington, D., Adriaenssens, A. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411413111 · Cited by 141 · cited 2×
“In the distal colon and rectum, L cells also produce insulin-like peptide-5 (INSL5), a hormone with reported orexigenic activity [3], and GLP-1, PYY and INSL5 are co-stored and coreleased from an overlapping vesicular pool in these cells [4].”
BackgroundSelf-citationGut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice
Song, Y., Koehler, J. A., Baggio, L. L., Powers, A. C., Sandoval, D. A., & Drucker, D. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.009 · Cited by 140 · cited 3×
“Plasma GLP-1 levels increase following oral glucose or meal ingestion, but not after intravenous glucose administration, suggesting the circulating peptide is largely gut-derived [32], whereas islet GLP-1 production has largely been reported in models of inflammation and diabetes [17, 33].”
BackgroundNauck, M. A., El-Ouaghlidi, A., Gabrys, B., Hücking, K., Holst, J. J., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Meier, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.020 · Cited by 137 · cited 1×
“Plasma GLP-1 levels increase following oral glucose or meal ingestion, but not after intravenous glucose administration, suggesting the circulating peptide is largely gut-derived [32], whereas islet GLP-1 production has largely been reported in models of inflammation and diabetes [17, 33].”
BackgroundBilling, L. J., Larraufie, P., Lewis, J., Leiter, A., Li, J., Lam, B., Yeo, G. S., Goldspink, D. A., Kay, R. G., Gribble, F. M., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.001 · Cited by 107 · cited 3×
“We showed previously that INSL5 is produced by the majority of L cells in the distal two-thirds of the mouse colon/rectum [22].”
BackgroundResultSelf-citationChristensen, L. W., Kuhre, R. E., Janus, C., Svendsen, B., & Holst, J. J. (2015) · Physiological Reports · doi:10.14814/phy2.12551 · Cited by 99 · cited 1×
“Colonic L cells are enriched for a variety of G-protein-coupled receptors, but although it would be tempting to speculate that these might be targetable with non-absorbable gut-restricted small molecules, several of the receptors seem to be located basolaterally on L cells [12, 52, 53], requiring local drug absorption.”
BackgroundGlass, L. L., Calero-Nieto, F. J., Jawaid, W., Larraufie, P., Kay, R. G., Göttgens, B., Reimann, F., & Gribble, F. M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.014 · Cited by 87 · cited 1×
“Direct activation of enterochromaffin cells seems unlikely, as only a small number of GFP-labelled cells stained positive for 5-HT, consistent with previous reports of only a small overlap of Gcg and Tph1-expressing cells in the small intestine [46] and colon [22].”
ResultSelf-citationTough, I., Forbes, S., Tolhurst, R., Ellis, M., Herzog, H., Bornstein, J., & Cox, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01401.x · Cited by 74 · cited 3×
“However, Y1R inhibition had no effect on accelerated faecal output in our model, consistent with NPY and/or PYY knockout resulting in increased rather than decreased faecal output in response to restraint-stress [27, 49], despite an apparent inhibition of colonic transit by Y1R inhibition in vitro [27].”
ResultInfluentialBilling, L. J., Smith, C. A., Larraufie, P., Goldspink, D. A., Galvin, S., Kay, R. G., Howe, J. D., Walker, R., Pruna, M., Glass, L., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.011 · Cited by 70 · cited 8×
“] for 6 h, 30% overnight) as previously described [4, 21].”
BackgroundMethodResultSelf-citationInsulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production
Lee, Y. S., De Vadder, F., Tremaroli, V., Wichmann, A., Mithieux, G., & Bäckhed, F. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.007 · Cited by 68 · cited 1×
“investigation into the role of colonic INSL5 is, nevertheless, warranted given the mixed reports that it exhibits orexigenic activity [3], modulates hepatic glucose production [38] and/or stimulates insulin secretion [39].”
BackgroundBile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents
Christiansen, C. B., Trammell, S. A. J., Wewer Albrechtsen, N. J., Schoonjans, K., Albrechtsen, R., Gillum, M. P., Kuhre, R. E., & Holst, J. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00010.2019 · Cited by 67 · cited 1×
“L cells in the colon and rectum also express G-protein-coupled receptors for shortchain fatty acids (SCFAs) [10] generated by the intestinal microbiome and for bile acids [11], which are incompletely absorbed in the distal ileum and modified by luminal bacteria, although the physiological importance of SCFAs for the r…”
BackgroundPanaro, B. L., Yusta, B., Matthews, D., Koehler, J. A., Song, Y., Sandoval, D. A., & Drucker, D. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100990 · Cited by 67
Shoblock, J. R., Welty, N., Nepomuceno, D. H., Lord, B., Aluisio, L. E., Fraser, I. C., Motley, S. T., Sutton, S. W., Morton, K. L., Galici, R., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1726-x · Cited by 61
Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents
Liu, Y. ‐., Ford, H. E., Druce, M. R., MINNION, J. S., Field, B. C. T., Shillito, J. C., Baxter, J. E., Murphy, K. G., Ghatei, M. A., & Bloom, S. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.110 · Cited by 55 · cited 1×
“Oxyntomodulin, which is co-produced with GLP-1 from the proglucagon peptide in L cells, has been shown to increase energy expenditure, likely through its activity on the glucagon receptor, although it was not found to increase locomotor activity [41, 42].”
BackgroundThe insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo
Luo, X., Li, T., Zhu, Y., Dai, Y., Zhao, J., Guo, Z.-Y., & Wang, M.-W. (2015) · Biochemical Journal · doi:10.1042/bj20141113 · Cited by 53 · cited 1×
“investigation into the role of colonic INSL5 is, nevertheless, warranted given the mixed reports that it exhibits orexigenic activity [3], modulates hepatic glucose production [38] and/or stimulates insulin secretion [39].”
BackgroundAngiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans
Pais, R., Rievaj, J., Larraufie, P., Gribble, F. M., & Reimann, F. (2016) · Endocrinology · doi:10.1210/en.2016-1384 · Cited by 45 · cited 1×
“leading to suggestions that the physiological roles of L cells in the distal gut may involve regulation of local processes such as fluid secretion, motility and intestinal repair [13, 14].”
BackgroundSelf-citationKuhre, R. E., Christiansen, C. B., Saltiel, M. Y., Wewer Albrechtsen, N. J., & Holst, J. J. (2017) · Physiological Reports · doi:10.14814/phy2.13507 · Cited by 40 · cited 1×
“Nevertheless, colonic L cells recapitulate the responsiveness of L cells from more proximal regions, secreting GLP-1 in response to a range of nutrientrelated stimuli, including glucose in primary cultures [6–8] and perfused colon preparations [9].”
BackgroundWang, L., Martı́nez, V., Kimura, H., & Taché, Y. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00289.2006 · Cited by 39 · cited 1×
“Both 5-HT3 and 5-HT4 receptors have been implicated previously in regulating faecal output in mice [43, 44].”
BackgroundPais, R., Rievaj, J., Meek, C. L., Costa, G. D., Jayamaha, S., Alexander, R. T., Reimann, F., & Gribble, F. M. (2016) · The Journal of Physiology · doi:10.1113/jp272053 · Cited by 37 · cited 1×
“leading to suggestions that the physiological roles of L cells in the distal gut may involve regulation of local processes such as fluid secretion, motility and intestinal repair [13, 14].”
BackgroundSelf-citationDevelopment and characterisation of a novel glucagon like peptide-1 receptor antibody
Biggs, E. K., Liang, L., Naylor, J., Madalli, S., Collier, R., Coghlan, M. P., Baker, D. J., Hornigold, D. C., Ravn, P., Reimann, F., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4491-0 · Cited by 37 · cited 1×
“For the GLP-1 receptor (GLP1R) antagonism studies, animals received either an isotype control antibody or a GLP1R blocking antibody (GLP1R0017), developed in collaboration with MedImmune/AstraZeneca (Cambridge, UK) [18], at 19.”
MethodSelf-citationThe penetration of doxycycline into CSF.
Andersson, H., & Alestig, K. (1976) · PubMed · Cited by 34
Forbes, S. C., & Cox, H. M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12428 · Cited by 30 · cited 1×
“However, Y1R inhibition had no effect on accelerated faecal output in our model, consistent with NPY and/or PYY knockout resulting in increased rather than decreased faecal output in response to restraint-stress [27, 49], despite an apparent inhibition of colonic transit by Y1R inhibition in vitro [27].”
ResultInsulin-Like Peptide 5: Expression in the Mouse Brain and Mobilization of Calcium
Dun, S. L., Brailoiu, E., Wang, Y., Brailoiu, G. C., Liu‐Chen, L., Yang, J., Chang, J. K., & Dun, N. J. (2006) · Endocrinology · doi:10.1210/en.2006-0237 · Cited by 28 · cited 2×
“Despite previous reports of Insl5expression in the hypothalamus [23], we were unable to detect reporter gene expression in the CNS of DOX-induced Insl5rtTAxGCaMP6ΔCMV mice [4], which expressed the reporter in the colon (ESM Fig.”
BackgroundGlycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy
Kim, K., Hutch, C. R., Wood, L., Magrisso, I. J., Seeley, R. J., & Sandoval, D. A. (2019) · JCI Insight · doi:10.1172/jci.insight.129452 · Cited by 28 · cited 2×
“The concept of GLP-1 as a gut-derived incretin hormone is not new but is currently controversial, as recent publications have identified the pancreas as a potential alternative source of GLP-1 [15, 16, 28].”
BackgroundThe role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice
Hutch, C. R., Roelofs, K., Haller, A., Sorrell, J., Leix, K., D’Alessio, D. D., Augustin, R., Seeley, R. J., Klein, T., & Sandoval, D. A. (2019) · Diabetologia · doi:10.1007/s00125-019-4963-5 · Cited by 22 · cited 1×
“The concept of GLP-1 as a gut-derived incretin hormone is not new but is currently controversial, as recent publications have identified the pancreas as a potential alternative source of GLP-1 [15, 16, 28].”
BackgroundSheng, K., Zhang, H., Yue, J., Gu, W., Gu, C., Zhang, H., & Wu, W. (2018) · Toxicology · doi:10.1016/j.tox.2018.04.007 · Cited by 17 · cited 13×
“Defecation quantified as faecal pellet output (a, c, e, g, i) and faecal weight (b, d, f, h, j) in response to vehicle or CNO (0.3 mg/kg i.p.) in LdistalDq animals (a, b) without or after pre-treatment with (c, d) ondansetron (3 mg/kg i.p.), (e, f) Y2R antagonist JNJ-31020028 (20 mg/kg i.p.), (g, h) Y1R antagonist BIB…”
BackgroundInfluentialThe involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice
Pascual, D., Alsasua, A., Goicoechea, C., & Martín, M. I. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00251-3 · Cited by 16 · cited 1×
“Both 5-HT3 and 5-HT4 receptors have been implicated previously in regulating faecal output in mice [43, 44].”
BackgroundInsulin-like peptide 5 fails to improve metabolism or body weight in obese mice
Zaykov, A. N., Gelfanov, V. M., Pérez–Tilve, D., Finan, B., & DiMarchi, R. D. (2019) · Peptides · doi:10.1016/j.peptides.2019.170116 · Cited by 13 · cited 1×
“Although we also here observe a possible orexigenic effect of INSL5, others have failed to observe effects on food intake even at pharmacological doses of chemically synthesised INSL5 (native and pegylated forms) [40].”
Background
Cited by
Internal senses of the vagus nerve
Prescott, S. L., & Liberles, S. D. (2022) · Neuron · doi:10.1016/j.neuron.2021.12.020 · Cited by 331
Metabolic messengers: glucagon-like peptide 1
Gribble, F. M., & Reimann, F. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00327-x · Cited by 199
Self-citationBlachier, F., Andriamihaja, M., Larraufie, P., Ahn, E., Lan, A., & Kim, E. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00261.2020 · Cited by 174
“EECs in the colon have also been shown to be involved in the regulation of metabolic functions despite not being directly stimulated by nutrients (57, 82) but rather by microbial-derived compounds (3, 52, 86).”
BackgroundThe intestine as an endocrine organ and the role of gut hormones in metabolic regulation
Bany Bakar, R., Reimann, F., & Gribble, F. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00830-y · Cited by 144
“The orexigenic effect of INSL5 is much lower than that of ghrelin, was not observed in some studies 215 , and is likely to be overwhelmed in vivo by PYY, which is secreted in parallel from the same EECs 216 .”
BackgroundSelf-citationNutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Lu, V. B., Gribble, F. M., & Reimann, F. (2021) · Nutrients · doi:10.3390/nu13030883 · Cited by 117
“Interestingly, direct stimulation of gut hormone release from distal L-cells, which increased both GLP-1 and PYY levels, reduced food intake as a result of PYY signalling through Y2 receptors [78].”
BackgroundSelf-citation
Metadata
- Authors
- Lewis, J. E., Miedzybrodzka, E. L., Foreman, R. E., Woodward, O. R. M., Kay, R. G., Goldspink, D. A., Gribble, F. M., & Reimann, F.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Gribble, Fiona M.
- Reimann, Frank
- ORCID
- Venue
- Diabetologia
- Published
- 2020-04-27
- Volume
- 63
- Issue
- 7
- Pages
- 1396-1407
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC7286941
- OpenAlex
- W3019726148
- Cited by
- 59
- References
- 54
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 15 · 2020: 3
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Apollo
- Funders
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust (106263/Z/14/Z)
- Medical Research Council (MRC_MC_UU_12012/3)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin-like peptide 5, glucagon-like peptide-1, peptide YY, DREADD, clozapine-N-oxide, glucose tolerance, dietary intake, body weight, energy expenditure, high-fat diet, GLP-1 receptor, 5-HT3 receptor, gut-brain signaling, metabolic homeostasis
- MeSH terms
- Animals, Colon, Insulin, L Cells, Male, Proteins, Enteroendocrine Cells, Peptide YY, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.